Cargando…

Prognostic effect of matrix metalloproteinase-9 in patients with resected Non small cell lung cancer

BACKGROUND: The role of tumor matrix metalloproteinase-9 (MMP-9) expression in non-small cell lung cancer (NSCLC) remains controversial. In this study, we investigated the prognostic value of tumor MMP-9 expression and other clinicopathologic factors in patients with completely resected NSCLC. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Chang Young, Shim, Hyo Sup, Lee, Seokkee, Lee, Jin Gu, Kim, Dae Joon, Chung, Kyung Young
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4379698/ https://www.ncbi.nlm.nih.gov/pubmed/25888323 http://dx.doi.org/10.1186/s13019-015-0248-3

Ejemplares similares

Pathologic Correlation of Serum Carcinoembryonic Antigen and Cytokeratin 19 Fragment in Resected Nonsmall Cell Lung Cancer
por: Lee, Seokkee, et al.
Publicado: (2013)

Factors Affecting the Number of Stapler Cartridges in Complete Video-Assisted Thoracoscopic Surgery Lobectomy for Non-small Cell Lung Cancer
por: Yang, Young Ho, et al.
Publicado: (2020)

The prognostic factors of resected non-small cell lung cancer with chest wall invasion
por: Lee, Chang Young, et al.
Publicado: (2012)

Autophagy contributes to the chemo-resistance of non-small cell lung cancer in hypoxic conditions
por: Lee, Jin Gu, et al.
Publicado: (2015)

Positive nodal status is still a risk factor for long-term survivors of non-small cell lung cancer 5 years after complete resection
por: Yang, Young Ho, et al.
Publicado: (2021)

Lung matrix metalloproteinase-9 correlates with cigarette smoking and obstruction of airflow.
por: Kang, Min Jong, et al.
Publicado: (2003)

The Prognostic Significance of Multiple Station N2 in Patients with Surgically Resected Stage IIIA N2 Non-small Cell Lung Cancer
por: Lee, Jin Gu, et al.
Publicado: (2008)

Prediction of postoperative pulmonary complications using preoperative controlling nutritional status (CONUT) score in patients with resectable non-small cell lung cancer
por: Lee, Sang Chul, et al.
Publicado: (2020)

Changes in the Demographics and Prognoses of Patients with Resected Non-Small Cell Lung Cancer: A 20-Year Experience at a Single Institution in Korea
por: Lee, Jin Gu, et al.
Publicado: (2012)

The Effect of Imiquimod on Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Malignant Melanoma Cell Invasion
por: Jung, Jin Young, et al.
Publicado: (2014)

Plasma Matrix Metalloproteinase-9 and Tissue Inhibitor of Matrix Metalloproteinase-1 as Prognostic Biomarkers in Critically Ill Patients
por: Duda, Izabela, et al.
Publicado: (2020)

Prognostic role of matrix metalloproteinase 9 in early breast cancer
por: Kalavska, Katarina, et al.
Publicado: (2021)

Pan-cancer analysis of the prognostic and immunological role of matrix metalloproteinase 9
por: Zhang, Jie, et al.
Publicado: (2023)

Feasibility and surgical outcomes of video‐assisted thoracoscopic pulmonary resection in patients with advanced‐stage lung cancer after neoadjuvant chemoradiotherapy
por: Suh, Jee Won, et al.
Publicado: (2019)

Predictors of Recurrence after Thymoma Resection
por: Bae, Mi Kyung, et al.
Publicado: (2013)

Matrix Metalloproteinase-2 and -7 Expression in Colorectal Cancer
por: Hong, Seong Woo, et al.
Publicado: (2011)

Correlation of expression and activity of matrix metalloproteinase-9 and -2 in human gingival cells of periodontitis patients
por: Kim, Kyung-A, et al.
Publicado: (2013)

Protein tyrosine phosphatase controls breast cancer invasion through the expression of matrix metalloproteinase-9
por: Hwang, Bo-Mi, et al.
Publicado: (2013)

Lack of Association between Matrix Metalloproteinase 8 Promoter Polymorphism and Bronchiectasis in Koreans
por: Lee, Jiwon, et al.
Publicado: (2007)

The association between the preoperative serum levels of lipocalin-2 and matrix metalloproteinase-9 (MMP-9) and prognosis of breast cancer
por: Sung, Hyuna, et al.
Publicado: (2012)

Microarray‐based Analysis of Anti‐angiogenic Activity of Demethoxycurcumin on Human Umbilical Vein Endothelial Cells: Crucial Involvement of the Down‐regulation of Matrix Metalloproteinase
por: Kim, Jin Hee, et al.
Publicado: (2002)

Matrix metalloproteinase-9 (MMP-9) Expression in Non-Small Cell Lung Carcinoma and Its Association with Clinicopathologic Factors
por: Jafarian, Amir Hossein, et al.
Publicado: (2020)

The frequency and clinical impact of HER2 alterations in lung adenocarcinoma
por: Kim, Eun Kyung, et al.
Publicado: (2017)

Clinical significance of C-Reactive Protein to Lymphocyte Count Ratio as a prognostic factor for Survival in Non-small Cell Lung Cancer Patients undergoing Curative Surgical Resection
por: Hwang, Jae-Joon, et al.
Publicado: (2021)

The role of matrix metalloproteinase-9 as a prognostic biomarker in papillary thyroid cancer
por: Zarkesh, Maryam, et al.
Publicado: (2018)

In vitro validation of the tear matrix metalloproteinase 9 in-situ immunoassay
por: Bang, Seung Pil, et al.
Publicado: (2020)

Plaque Rupture is a Determinant of Vascular Events in Carotid Artery Atherosclerotic Disease: Involvement of Matrix Metalloproteinases 2 and 9
por: Heo, Sung Hyuk, et al.
Publicado: (2011)

Elevated matrix metalloproteinase-9 in patients with systemic sclerosis
por: Kim, Wan-Uk, et al.
Publicado: (2005)

Involvement of Matrix Metalloproteinase 9 in Vertebral Arterial Dissection With Posterior Circulation Ischemic Stroke
por: Chen, Chun‐Yu, et al.
Publicado: (2020)

Matrix metalloproteinases in lung biology
por: Parks, William C, et al.
Publicado: (2001)

Correlation of matrix metalloproteinase 3 and matrix metalloproteinase 9 levels with non-motor symptoms in patients with Parkinson’s disease
por: Liu, Chuan Ze, et al.
Publicado: (2022)

Differential Expression of Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Thioacetamide-Induced Chronic Liver Injury
por: Park, Soo Young, et al.
Publicado: (2010)

Matrix metalloproteinase-7 and matrix metalloproteinase-9 are associated with unfavourable prognosis in superficial oesophageal cancer
por: Tanioka, Y, et al.
Publicado: (2003)

Interleukin-33, matrix metalloproteinase-9, and tissue ınhibitor of matrix metalloproteinase-1 in myocardial infarction
por: Guzel, Savas, et al.
Publicado: (2013)

Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis Patients
por: Trentini, Alessandro, et al.
Publicado: (2016)

Matrix Metalloproteinase-1 and Matrix Metalloproteinase-9 in the Aqueous Humor of Diabetic Macular Edema Patients
por: Kwon, Jin-woo, et al.
Publicado: (2016)

Increased Serum Activity of Matrix Metalloproteinase-9 in Patients with Acute Variceal Bleeding
por: Kwon, Oh Sang, et al.
Publicado: (2012)

Importance of tear volume for positivity of tear matrix metalloproteinase-9 immunoassay
por: Jun, Jong Hwa, et al.
Publicado: (2020)

Increased matrix metalloproteinase-9 to tissue inhibitor of metalloproteinase-1 ratio in smokers with airway hyperresponsiveness and accelerated lung function decline
por: Lo, Chun-Yu, et al.
Publicado: (2018)

Effects of Mesenchymal Stem Cell Treatment on the Expression of Matrix Metalloproteinases and Angiogenesis during Ischemic Stroke Recovery
por: Nam, Hyo Suk, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_f18dprl48kbpvpv77lc0h0dn74